These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12946512)

  • 1. Comparison of intermittent-bolus contrast imaging with conventional power Doppler sonography: quantification of tumour perfusion in small animals.
    Krix M; Kiessling F; Vosseler S; Kiessling I; Le-Huu M; Fusenig NE; Delorme S
    Ultrasound Med Biol; 2003 Aug; 29(8):1093-103. PubMed ID: 12946512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive noninvasive monitoring of tumor perfusion during antiangiogenic therapy by intermittent bolus-contrast power Doppler sonography.
    Krix M; Kiessling F; Vosseler S; Farhan N; Mueller MM; Bohlen P; Fusenig NE; Delorme S
    Cancer Res; 2003 Dec; 63(23):8264-70. PubMed ID: 14678984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multivessel model describing replenishment kinetics of ultrasound contrast agent for quantification of tissue perfusion.
    Krix M; Kiessling F; Farhan N; Schmidt K; Hoffend J; Delorme S
    Ultrasound Med Biol; 2003 Oct; 29(10):1421-30. PubMed ID: 14597339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing dynamic parameters of tumor vascularization in nude mice revealed by magnetic resonance imaging and contrast-enhanced intermittent power Doppler sonography.
    Kiessling F; Krix M; Heilmann M; Vosseler S; Lichy M; Fink C; Farhan N; Kleinschmidt K; Schad L; Fusenig NE; Delorme S
    Invest Radiol; 2003 Aug; 38(8):516-24. PubMed ID: 12874518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of high frequency ultrasound methods and contrast agents for characterising tumor response to anti-angiogenic treatment.
    Rix A; Lederle W; Siepmann M; Fokong S; Behrendt FF; Bzyl J; Grouls C; Kiessling F; Palmowski M
    Eur J Radiol; 2012 Oct; 81(10):2710-6. PubMed ID: 22093958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intra-Animal Comparison between Three-dimensional Molecularly Targeted US and Three-dimensional Dynamic Contrast-enhanced US for Early Antiangiogenic Treatment Assessment in Colon Cancer.
    Wang H; Lutz AM; Hristov D; Tian L; Willmann JK
    Radiology; 2017 Feb; 282(2):443-452. PubMed ID: 27490690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of consecutive bolus tracking and flash replenishment measurements for the assessment of tissue hemodynamics using contrast-enhanced ultrasound (CEUS) in an experimental human squamous cell carcinoma model.
    Paprottka PM; Ingrisch M; Koelln A; Zengel P; Cyran CC; Nikolaou K; Reiser MF; Clevert DA
    Clin Hemorheol Microcirc; 2012; 52(2-4):107-14. PubMed ID: 22960296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of skeletal muscle perfusion using contrast-enhanced ultrasonography.
    Krix M; Weber MA; Krakowski-Roosen H; Huttner HB; Delorme S; Kauczor HU; Hildebrandt W
    J Ultrasound Med; 2005 Apr; 24(4):431-41. PubMed ID: 15784761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The vascularisation of oral cavity tumours and tumour shell tissue determined by three-dimensional power Doppler sonography.
    Rebol J
    Ultrasound Med Biol; 2007 Apr; 33(4):493-9. PubMed ID: 17316963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved flow measurement using microbubble contrast agents and disruption-replenishment: clinical application to tumour monitoring.
    Hudson JM; Williams R; Lloyd B; Atri M; Kim TK; Bjarnason G; Burns PN
    Ultrasound Med Biol; 2011 Aug; 37(8):1210-21. PubMed ID: 21683508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution ultrasound perfusion imaging of therapeutic angiogenesis.
    Rissanen TT; Korpisalo P; Karvinen H; Liimatainen T; Laidinen S; Gröhn OH; Ylä-Herttuala S
    JACC Cardiovasc Imaging; 2008 Jan; 1(1):83-91. PubMed ID: 19356410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quantification of tissue perfusion with novel ultrasound methods].
    Krix M; Kauczor HU; Delorme S
    Radiologe; 2003 Oct; 43(10):823-30. PubMed ID: 14605698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging.
    Pysz MA; Foygel K; Panje CM; Needles A; Tian L; Willmann JK
    Invest Radiol; 2011 Mar; 46(3):187-95. PubMed ID: 21150790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast ultrasonography: necessity of linear data processing for the quantification of tumor vascularization.
    Peronneau P; Lassau N; Leguerney I; Roche A; Cosgrove D
    Ultraschall Med; 2010 Aug; 31(4):370-8. PubMed ID: 20577941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between estimates of tumor perfusion from microbubble contrast-enhanced sonography and dynamic contrast-enhanced magnetic resonance imaging.
    Yankeelov TE; Niermann KJ; Huamani J; Kim DW; Quarles CC; Fleischer AC; Hallahan DE; Price RR; Gore JC
    J Ultrasound Med; 2006 Apr; 25(4):487-97. PubMed ID: 16567438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular flow and perfusion imaging with ultrasound contrast agents.
    Bruce M; Averkiou M; Tiemann K; Lohmaier S; Powers J; Beach K
    Ultrasound Med Biol; 2004 Jun; 30(6):735-43. PubMed ID: 15219953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.
    Ellegala DB; Leong-Poi H; Carpenter JE; Klibanov AL; Kaul S; Shaffrey ME; Sklenar J; Lindner JR
    Circulation; 2003 Jul; 108(3):336-41. PubMed ID: 12835208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of conventional time-intensity curves vs. maximum intensity over time for post-processing of dynamic contrast-enhanced ultrasound.
    Palmowski M; Lederle W; Gaetjens J; Socher M; Hauff P; Bzyl J; Semmler W; Günther RW; Kiessling F
    Eur J Radiol; 2010 Jul; 75(1):e149-53. PubMed ID: 19945241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring tumor perfusion in control and treated murine tumors: correlation of microbubble contrast-enhanced sonography to dynamic contrast-enhanced magnetic resonance imaging and fluorodeoxyglucose positron emission tomography.
    Niermann KJ; Fleischer AC; Huamani J; Yankeelov TE; Kim DW; Wilson WD; Hallahan DE
    J Ultrasound Med; 2007 Jun; 26(6):749-56. PubMed ID: 17526606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Power Doppler ultrasound and contrast-enhanced ultrasound demonstrate non-invasive tumour vascular response to anti-vascular therapy in canine cancer patients.
    Abma E; Stock E; De Spiegelaere W; Van Brantegem L; Vanderperren K; Ni Y; Vynck M; Daminet S; De Clercq K; de Rooster H
    Sci Rep; 2019 Jun; 9(1):9262. PubMed ID: 31239493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.